Troy A. Ignelzi
CIK 1579829 · Chief Financial Officer · last filed 2026-04-06
Troy A. Ignelzi is a Chief Financial Officer who has filed 39 SEC Form 4 insider transactions across 6 companies since 2018. The most recent filing, for HRMY, was dated Apr 6, 2026. Across all open-market trades the lifetime net is −$25.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $384.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$384.0K
6
39
-$25.69M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HRMY | Director | — | $34.46 | — | $0 | 1 | 2026-04-06 |
| RAPP | Chief Financial Officer | 10,000 | $38.40 | $384.0K | $101.0K | 4 | 2026-02-04 |
| CTNM | Director | — | $11.88 | — | $0 | 3 | 2025-06-26 |
| Karuna Therapeutics, Inc. (KRTX) Delisted | Chief Financial Officer | 31,907 | $329.83 | $10.52M | -$25.79M | 29 | 2023-08-24 |
| CinCor Pharma, Inc. (CINC) Delisted | Director | — | $29.06 | — | $0 | 1 | 2023-02-24 |
| scPharmaceuticals Inc. (SCPH) Delisted | Chief Financial Officer | — | $5.67 | — | $0 | 1 | 2018-01-19 |
Recent Filings
39 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-06 | HRMY | Grant (A) | — | $0 | EDGAR |
| 2026-02-04 | RAPP | Grant (A) | — | $0 | EDGAR |
| 2025-06-26 | CTNM | Grant (A) | — | $0 | EDGAR |
| 2025-03-13 | RAPP | Buy (P) | +10,000 | $101.0K | EDGAR |
| 2025-02-04 | RAPP | Grant (A) | — | $0 | EDGAR |
| 2024-06-10 | RAPP | Grant (A) | — | $0 | EDGAR |
| 2024-05-29 | CTNM | Grant (A) | — | $0 | EDGAR |
| 2024-05-20 | CTNM | Grant (A) | — | $0 | EDGAR |
| 2023-08-24 | Karuna Therapeutics, Inc. (KRTX) Delisted | Mixed | — | -$248.9K | EDGAR |
| 2023-05-25 | Karuna Therapeutics, Inc. (KRTX) Delisted | Mixed | — | -$1.93M | EDGAR |